Thomas L. Schwartz, MD: Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series

Name: Thomas L. Schwartz, MD: Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series
SKU: 3008
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 37 No. 1 Articles Tags: antidepressants, antipsychotics, mark-beale, medworks-media, obesity, psychopharmacology-bulletin, thomas-l-schwartz, weight-management

Description

Thomas L. Schwartz, MD: Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series

Description

Thomas L. Schwartz, MD

CASE HISTORIES

Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series

Thomas L. Schwartz, MD, and Mark Beale, MD

Monoarthritis Induced by Bupropion Hydrochloride by Barry N. Williams

Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination by Samir Kumar Praharaj

What Mood Symptoms may be most Difficult to Rate?

Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas

Thomas L. Schwartz, MD: Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series

Description

Thomas L. Schwartz, MD

CASE HISTORIES

Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series

Thomas L. Schwartz, MD, and Mark Beale, MD

Related products

Monoarthritis Induced by Bupropion Hydrochloride by Barry N. Williams

Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination by Samir Kumar Praharaj

What Mood Symptoms may be most Difficult to Rate?

Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas